𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of infliximab in resistant psoriatic arthritis

✍ Scribed by Salvarani, Carlo ;Cantini, Fabrizio ;Olivieri, Ignazio ;Macchioni, Pierluigi ;Padula, Angela ;Niccoli, Laura ;Catanoso, Maria Grazia ;Scocco, Giovanni Lo ;Boiardi, Luigi

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
70 KB
Volume
49
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The safety and efficacy of leflunomide i
The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis
✍ Hansen, K. E. ;Cush, J. ;Singhal, A. ;A. Cooley, D. ;Cohen, S. ;Patel, S. R. ;Ge πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 1 views

## Objective: To report the safety and efficacy of leflunomide (lef) in combination with infliximab (inf) for the treatment of rheumatoid arthritis. ## Methods: In an open, multicenter, retrospective study, data were collected on the safety and efficacy of lef and inf. ## Results: Eighty-eight

Antiangiogenic effects of anti–tumor nec
Antiangiogenic effects of anti–tumor necrosis factor Ξ± therapy with infliximab in psoriatic arthritis
✍ Juan D. CaΓ±ete; JosΓ© L. Pablos; Raimon SanmartΓ­; Carmen MallofrΓ©; Sara Marsal; J πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 217 KB πŸ‘ 1 views

## Abstract ## Objective Neovascularization, with an increased number of synovial vessels with a characteristic morphology, seems to contribute to the progression of psoriatic arthritis (PsA). Accordingly, angiogenesis may be an important therapeutic target in PsA. The aim of this study was to ana

Prevalence of malignancy in psoriatic ar
Prevalence of malignancy in psoriatic arthritis
✍ Sherry Rohekar; Brian D. M. Tom; Agnes Hassa; Cathy T. Schentag; Vernon T. Farew πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 194 KB πŸ‘ 2 views

## Abstract ## Objective To determine the prevalence and types of malignancy in a large cohort of patients with psoriatic arthritis (PsA), and to compare this rate with that in the general population. ## Methods A cohort analysis of patients who were followed up prospectively from 1978 to 2004 a